MODalyseR - a novel software for inference of disease module hub regulators identified a putative multiple sclerosis regulator supported by independent eQTL data

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Motivation: Network-based disease modules have proven to be a powerful concept for extracting knowledge about disease mechanisms, predicting for example disease risk factors and side effects of treatments. Plenty of tools exist for the purpose of module inference, but less effort has been put on simultaneously utilizing knowledge about regulatory mechanisms for predicting disease module hub regulators. Results: We developed MODalyseR, a novel software for identifying disease module regulators and reducing modules to the most disease-associated genes. This pipeline integrates and extends previously published software packages MODifieR and ComHub and hereby provides a user-friendly network medicine framework combining the concepts of disease modules and hub regulators for precise disease gene identification from transcriptomics data. To demonstrate the usability of the tool, we designed a case study for multiple sclerosis that revealed IKZF1 as a promising hub regulator, which was supported by independent ChIP-seq data.

Cite

CITATION STYLE

APA

De Weerd, H. A., Åkesson, J., Guala, D., Gustafsson, M., & Lubovac-Pilav, Z. (2022). MODalyseR - a novel software for inference of disease module hub regulators identified a putative multiple sclerosis regulator supported by independent eQTL data. Bioinformatics Advances, 2(1). https://doi.org/10.1093/bioadv/vbac006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free